Matches in SemOpenAlex for { <https://semopenalex.org/work/W3212640467> ?p ?o ?g. }
- W3212640467 endingPage "172" @default.
- W3212640467 startingPage "165" @default.
- W3212640467 abstract "We compared the efficacy of the second-generation basal insulin degludec (IDeg) to that of insulin aspart via pump using continuous glucose monitoring in patients with well-controlled type 1 diabetes.In this 40-week, single-center, randomized, crossover-controlled trial, adults with well-controlled type 1 diabetes (hemoglobin A1C of <7.5% [<58 mmol/mol]) (N = 52) who were using an insulin pump and continuous glucose monitoring were randomized to 1 of 2 treatments for a 20-week period: a single daily injection of IDeg with bolus aspart via pump or a continuous subcutaneous insulin infusion (CSII) with aspart, followed by crossover to the other treatment. The primary endpoint was time in range (70-180 mg/dL) during the final 2 weeks of each treatment period.Fifty-two patients were randomized and completed both treatment periods. The time in range for IDeg and CSII was 71.5% and 70.9%, respectively (P = .553). The time in level 1 hypoglycemia for the 24-hour period with IDeg and CSII was 2.19% and 1.75%, respectively (P = .065). The time in level 2 hypoglycemia for the 24-hour period with IDeg and CSII was 0.355% and 0.271%, respectively (P = .212), and the nocturnal period was 0.330% and 0.381%, respectively (P = .639). The mean standard deviation of blood glucose levels for the 24-hour period for IDeg and CSII was 52.4 mg/dL and 51.0 mg/dL, respectively (P = .294). The final hemoglobin A1C level for each treatment was 7.04% (53 mmol/mol) with IDeg, and 6.95% (52 mmol/mol) with CSII (P = .288). Adverse events were similar between treatments.We observed similar glycemic control between IDeg and insulin aspart via CSII for basal insulin coverage in patients with well-controlled type 1 diabetes." @default.
- W3212640467 created "2021-11-22" @default.
- W3212640467 creator A5012426357 @default.
- W3212640467 creator A5019023547 @default.
- W3212640467 creator A5043422189 @default.
- W3212640467 creator A5073112110 @default.
- W3212640467 creator A5087491613 @default.
- W3212640467 date "2022-02-01" @default.
- W3212640467 modified "2023-09-27" @default.
- W3212640467 title "Basal Insulin Degludec and Glycemic Control Compared to Aspart Via Insulin Pump in Type 1 Diabetes (BIGLEAP): A Single-Center, Open-Label, Randomized, Crossover Trial" @default.
- W3212640467 cites W1658549429 @default.
- W3212640467 cites W1973361408 @default.
- W3212640467 cites W2034327086 @default.
- W3212640467 cites W2125676337 @default.
- W3212640467 cites W2138613293 @default.
- W3212640467 cites W2149637692 @default.
- W3212640467 cites W2152591579 @default.
- W3212640467 cites W2582695911 @default.
- W3212640467 cites W2582943213 @default.
- W3212640467 cites W2587843318 @default.
- W3212640467 cites W2589083807 @default.
- W3212640467 cites W2769264260 @default.
- W3212640467 cites W2789777142 @default.
- W3212640467 cites W2883680491 @default.
- W3212640467 cites W2909166675 @default.
- W3212640467 cites W2928844361 @default.
- W3212640467 cites W2948261890 @default.
- W3212640467 cites W2968305708 @default.
- W3212640467 cites W2970309842 @default.
- W3212640467 cites W2974459507 @default.
- W3212640467 cites W3028550899 @default.
- W3212640467 cites W3031073495 @default.
- W3212640467 cites W3043664475 @default.
- W3212640467 cites W3099316592 @default.
- W3212640467 cites W3118986275 @default.
- W3212640467 cites W3186558830 @default.
- W3212640467 doi "https://doi.org/10.1016/j.eprac.2021.11.001" @default.
- W3212640467 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34763071" @default.
- W3212640467 hasPublicationYear "2022" @default.
- W3212640467 type Work @default.
- W3212640467 sameAs 3212640467 @default.
- W3212640467 citedByCount "2" @default.
- W3212640467 countsByYear W32126404672022 @default.
- W3212640467 countsByYear W32126404672023 @default.
- W3212640467 crossrefType "journal-article" @default.
- W3212640467 hasAuthorship W3212640467A5012426357 @default.
- W3212640467 hasAuthorship W3212640467A5019023547 @default.
- W3212640467 hasAuthorship W3212640467A5043422189 @default.
- W3212640467 hasAuthorship W3212640467A5073112110 @default.
- W3212640467 hasAuthorship W3212640467A5087491613 @default.
- W3212640467 hasConcept C126322002 @default.
- W3212640467 hasConcept C134018914 @default.
- W3212640467 hasConcept C142724271 @default.
- W3212640467 hasConcept C168563851 @default.
- W3212640467 hasConcept C203092338 @default.
- W3212640467 hasConcept C204787440 @default.
- W3212640467 hasConcept C27081682 @default.
- W3212640467 hasConcept C2775927303 @default.
- W3212640467 hasConcept C2777180221 @default.
- W3212640467 hasConcept C2779306644 @default.
- W3212640467 hasConcept C2779794567 @default.
- W3212640467 hasConcept C2779908123 @default.
- W3212640467 hasConcept C2779920387 @default.
- W3212640467 hasConcept C2780473172 @default.
- W3212640467 hasConcept C2780668416 @default.
- W3212640467 hasConcept C2781232474 @default.
- W3212640467 hasConcept C555293320 @default.
- W3212640467 hasConcept C71924100 @default.
- W3212640467 hasConcept C87813604 @default.
- W3212640467 hasConcept C90924648 @default.
- W3212640467 hasConceptScore W3212640467C126322002 @default.
- W3212640467 hasConceptScore W3212640467C134018914 @default.
- W3212640467 hasConceptScore W3212640467C142724271 @default.
- W3212640467 hasConceptScore W3212640467C168563851 @default.
- W3212640467 hasConceptScore W3212640467C203092338 @default.
- W3212640467 hasConceptScore W3212640467C204787440 @default.
- W3212640467 hasConceptScore W3212640467C27081682 @default.
- W3212640467 hasConceptScore W3212640467C2775927303 @default.
- W3212640467 hasConceptScore W3212640467C2777180221 @default.
- W3212640467 hasConceptScore W3212640467C2779306644 @default.
- W3212640467 hasConceptScore W3212640467C2779794567 @default.
- W3212640467 hasConceptScore W3212640467C2779908123 @default.
- W3212640467 hasConceptScore W3212640467C2779920387 @default.
- W3212640467 hasConceptScore W3212640467C2780473172 @default.
- W3212640467 hasConceptScore W3212640467C2780668416 @default.
- W3212640467 hasConceptScore W3212640467C2781232474 @default.
- W3212640467 hasConceptScore W3212640467C555293320 @default.
- W3212640467 hasConceptScore W3212640467C71924100 @default.
- W3212640467 hasConceptScore W3212640467C87813604 @default.
- W3212640467 hasConceptScore W3212640467C90924648 @default.
- W3212640467 hasFunder F4320322436 @default.
- W3212640467 hasIssue "2" @default.
- W3212640467 hasLocation W32126404671 @default.
- W3212640467 hasLocation W32126404672 @default.
- W3212640467 hasOpenAccess W3212640467 @default.
- W3212640467 hasPrimaryLocation W32126404671 @default.
- W3212640467 hasRelatedWork W2197938513 @default.
- W3212640467 hasRelatedWork W2276271282 @default.